# Two-Year Follow-up of Investigator-Initiated Phase 1 Trials of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells (CT053) in Relapsed/Refractory Multiple Myeloma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/two-year-follow-up-of-investigator-initiated-phase-1-trials-of-the-safety-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Siguo Hao,Jie Jin,Songfu Jiang,Zonghai Li,Wenhao Zhang,Min Yang,Kang Yu,Wei Wang,Linjun Chen,Haitao Meng,Mingxia He,Jun Xiao,Rong Tao,Xin Huang,Chongyun Xing,Daijing Yuan,Jian‐Bo Wan,Shasha Wang,Lihui Dai,Hong Ma |
| Citations | 36 |
| DOI | 10.1182/blood-2020-140156 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3095691155 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Songfu Jiang](https://scholariq.org/researchers/songfu-jiang/)

## Paper journal

- [Blood](https://scholariq.org/journals/blood/)

## Paper primary topic

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Paper topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.